Agranulocytosis Induced by Proton Pump Inhibitors;Two Cases of Fatal Antimalarial-Induced Cardiomyopathy;Oxaliplatin-Induced Thrombotic Thrombocytopenic Purpura;Unique Skin Eruption Caused by Telaprevir;Acute-Onset Opioid-Induced Hyperalgesia in a Child;Risk of Sharing a Pill Cutter;Dementia and Risk of Adverse Warfarin-Related Events in Nursing Homes;Comparative Rates of Adverse Events with Parenteral Formulations of Iron

Abstract

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA's) MedWatch program (800-FDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with our readers.